Discovery of Herbacetin as a Novel SGK1 Inhibitor to Alleviate Myocardial Hypertrophy (Adv. Sci. 2/2022)
نویسندگان
چکیده
Herbacetin In article number 2101485, Xiaoping Zhao, Yi Wang, and co-workers describe that herbacetin (HBT) derived from traditional Chinese medicine Rhodiola rosea (known as “golden root” in Europe) is identified a novel SGK1 inhibitor to significantly alleviate myocardial hypertrophy, which brings dawn patients with heart failure well other SGK1-driven diseases.
منابع مشابه
Contents: (Adv. Sci. 6/2017)
On-demand, ultra-high precision delivery of molecules and cells is of great importance in the field of controlled release. In article number 1600410, inspired by sea sponges, Lei Yang, Yuekun Lai, and co-workers design and fabricate a biomimetic macroporous ceramic composite sponge which reveals unique precise AND logic release behaviors of molecules and cells in response to dual-gates of moist...
متن کاملMasthead: (Adv. Sci. 4/2017)
Open Access and Copyright: All articles published by Advanced Science are fully open access: immediately freely available to read, download and share. All articles are published under the terms of the Creative Commons Attribution License (CC-BY). The CC-BY license permits use, distribution and reproduction in any medium, provided the original work is properly cited and allows the commercial use...
متن کاملMasthead: (Adv. Sci. 6/2015)
Open Access and Copyright: All articles published by Advanced Science are fully open access: immediately freely available to read, download and share. All articles are published under the terms of the Creative Commons Attribution License (CC-BY). The CC-BY license permits use, distribution and reproduction in any medium, provided the original work is properly cited and allows the commercial use...
متن کاملMasthead: (Adv. Sci. 6/2017)
Open Access and Copyright: All articles published by Advanced Science are fully open access: immediately freely available to read, download and share. All articles are published under the terms of the Creative Commons Attribution License (CC-BY). The CC-BY license permits use, distribution and reproduction in any medium, provided the original work is properly cited and allows the commercial use...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Advanced Science
سال: 2022
ISSN: ['2198-3844']
DOI: https://doi.org/10.1002/advs.202270009